INTAL (Cromolyn Sodium – Fisons), a Monograph. [Hardcover] Fisons Corporation.

Description

Some normal wear. Pages are clean. Dust jacket has some wear.

This rare monograph, published by the pharmaceutical company Fisons Corporation, offers a comprehensive look at the groundbreaking drug Cromolyn Sodium, marketed under the brand name INTAL. Developed in the late 1960s, Cromolyn Sodium was the first non-steroidal anti-inflammatory drug approved for the treatment of asthma, a significant breakthrough in respiratory medicine. This copy bears the marks of its age, with a well-preserved interior and a dust jacket showing signs of careful handling over the decades. For collectors and researchers interested in the history of modern pharmacology, this monograph provides invaluable insights into the development and early clinical trials of a drug that revolutionized the management of chronic respiratory conditions. With its detailed scientific data and historical context, this volume offers a fascinating glimpse into the cutting-edge research and innovation that shaped the pharmaceutical industry in the latter half of the 20th century.